1.Improvement of molecular adsorbent recirculating system on chronic severe hepatitis patients with multiple organ failure.
Xiao-bing HU ; Zhan YANG ; Xiao-ping TANG ; Min-min WANG ; Ying ZHOU ; Shu-ping LI
Chinese Journal of Hepatology 2003;11(10):629-630
Adult
;
Female
;
Hepatic Encephalopathy
;
diagnosis
;
etiology
;
therapy
;
Hepatitis B, Chronic
;
complications
;
therapy
;
Humans
;
Liver Failure, Acute
;
diagnosis
;
therapy
;
Liver, Artificial
;
Male
;
Middle Aged
;
Multiple Organ Failure
;
complications
;
therapy
;
Prognosis
;
Sorption Detoxification
2.Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation.
Se Hoon OH ; Joon Hyoek LEE ; Ji Won HWANG ; Hye Young KIM ; Chang Hoon LEE ; Geum Youn GWAK ; Moon Seok CHOI ; Kwang Chul KOH ; Seung Woon PAIK ; Byung Chul YOO
The Korean Journal of Hepatology 2009;15(3):362-369
Hepatitis A is generally known as a mild, self-limiting disease of the liver, but in rare instances it can progress to fulminant hepatitis, which may require liver transplantation for recovery. Such cases are known to be related to old age and underlying liver disease. We report four cases of hepatitis A in which patients presented with fulminant hepatitis and acute renal failure and underwent liver transplantation. The following common features were observed in our cases: (1) occurrence in relatively old age (> or =39 years old), (2) association with acute renal failure, (3) presence of hepatomegaly, and (4) microscopic features of submassive hepatic necrosis.
Adult
;
Age Factors
;
Female
;
Hepatitis/complications/*diagnosis/therapy
;
Hepatitis A/complications/*diagnosis
;
Hepatomegaly/diagnosis/etiology
;
Humans
;
Kidney Failure, Acute/complications/*diagnosis
;
Liver/pathology
;
Liver Cirrhosis/diagnosis/etiology
;
*Liver Transplantation
;
Male
;
Tomography, X-Ray Computed
3.Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes.
Jin Dong KIM ; Jong Young CHOI ; Chung Hwa PARK ; Myeong Jun SONG ; Jeong Won JANG ; Si Hyun BAE ; Seung Kew YOON ; Young Sok LEE ; Young Kyoung YOU ; Dong Goo KIM
The Korean Journal of Hepatology 2010;16(1):19-28
BACKGROUND/AIMS: According to recent prevalence of hepatitis A virus (HAV) infection, acute liver failure (ALF) due to HAV infection is observed frequently in parallel. The aim of this study was to elucidate the clinical, laboratory, and pathologic features of patients who have undergone emergency liver transplantation (LT) due to fulminant HAV infection. METHODS: Clinical, laboratory, and pathologic data of 11 transplant recipients with anti-HAV IgM-positive ALF between December 2007 and May 2009 were analyzed, and compared with data of 10 recipients who underwent LT for the management of ALF due to other causes. RESULTS: The median age of the patients with HAV-related ALF was 34 years (range: 15-43 years). The levels of hemoglobin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were higher and the level of bilirubin was lower in the HAV-related ALF group than in the other group (P=0.005, 0.001, 0.001, 0.010, and 0.003, respectively). The time from the onset of initial symptoms to the development of encephalopathy was shorter in the HAV-related ALF group than in the other group (median 5 days, range: 4-13 days; P<0.001). In patients with HAV-related ALF, laboratory findings and clinical prognostic parameters including the Acute Liver Failure Study Group prognostic index, King's College criteria, and model for endstage liver disease (MELD) and Child-Pugh scores were not associated with the grade of hepatic encephalopathy or time of progression to encephalopathy. CONCLUSIONS: The results of this study indicate that the clinical condition of patients with HAV-related ALF requiring emergency LT aggravates rapidly. Prognostic parameters are not sufficient for discriminating transplant candidates in patients with fulminant hepatitis A.
Adolescent
;
Adult
;
Aged
;
Alanine Transaminase/blood
;
Aspartate Aminotransferases/blood
;
Bilirubin/blood
;
Creatine/blood
;
Emergencies
;
Female
;
Hemoglobins/analysis
;
Hepatitis A/*complications
;
Hepatitis A Antibodies/immunology/metabolism
;
Humans
;
Immunoglobulin M/metabolism
;
Liver Failure, Acute/complications/*diagnosis/therapy
;
*Liver Transplantation
;
Male
;
Middle Aged
;
Prognosis
;
Severity of Illness Index
;
Time Factors
4.Successful extracorporeal liver dialysis for the treatment of trimethoprim-sulfamethoxazole-induced fulminant hepatic failure.
Choon Ta NG ; Chee Kiat TAN ; Choon Chiat OH ; Jason Pik Eu CHANG
Singapore medical journal 2013;54(5):e113-6
Trimethoprim-sulfamethoxazole (TMP-SMZ) is a commonly used antibiotic that has been associated with drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. DRESS syndrome is characterised by fever, rash, lymphadenopathy, eosinophilia and one or more major organ involvement. Although rare, TMP-SMZ is a recognised cause of fulminant hepatic failure. We report a 17-year-old Chinese male adolescent who presented with fever, myalgia, generalised maculopapular rash and lymphadenopathy after taking TMP-SMZ for acne vulgaris. He subsequently developed hepatic encephalopathy and was worked up for urgent liver transplantation. He responded well to extracorporeal liver dialysis (originally intended as a bridging therapy) and subsequently recovered without the need for liver transplantation. This case report highlights the importance of early recognition of TMP-SMZ-induced DRESS syndrome and the need for early discontinuation of the drug in the affected patient. Extracorporeal liver dialysis and transplantation should be considered in the management of TMP-SMZ-induced fulminant hepatic failure.
Acne Vulgaris
;
complications
;
drug therapy
;
Adolescent
;
Anti-Infective Agents
;
adverse effects
;
Biopsy
;
Drug Eruptions
;
etiology
;
Drug Hypersensitivity Syndrome
;
diagnosis
;
etiology
;
Fever
;
etiology
;
Humans
;
Liver Failure, Acute
;
etiology
;
therapy
;
Lymphatic Diseases
;
etiology
;
Male
;
Myalgia
;
etiology
;
Renal Dialysis
;
methods
;
Skin
;
pathology
;
Treatment Outcome
;
Trimethoprim, Sulfamethoxazole Drug Combination
;
adverse effects
5.Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Jung Min HA ; Won SOHN ; Ju Yeon CHO ; Jeung Hui PYO ; Kyu CHOI ; Dong Hyun SINN ; Geum Youn GWAK ; Moon Seok CHOI ; Joon Hyeok LEE ; Kwang Chul KOH ; Seung Woon PAIK ; Byung Chul YOO ; Yong Han PAIK
Clinical and Molecular Hepatology 2015;21(3):232-241
BACKGROUND/AIMS: Hepatitis-B-related acute-on-chronic liver failure has a poor prognosis. However, the advent of potent oral antiviral agents means that some patients can now recover with medical treatment. We aimed to identify the prognostic factors for hepatitis-B-related acute-on-chronic liver failure including the initial as well as the dynamically changing clinical parameters during admission. METHODS: Sixty-seven patients were retrospectively enrolled from 2003 to 2012 at Samsung Medical Center. The patients were classified into three categories: Recovery group (n=23), Liver transplantation group (n=28), and Death group (n=16). The Liver transplantation and Death groups were combined into an Unfavorable prognosis group. We analyzed the prognostic factors including the Model for End-Stage Liver Disease (MELD) scores determined at 3-day intervals. RESULTS: A multivariable analysis showed that the unfavorable prognostic factors were a high initial MELD score (> or =28) (odds ratio [OR] =6.64, p=0.015), moderate-to-severe ascites at admission (OR=6.71, P=0.012), and the aggravation of hepatic encephalopathy during hospitalization (> or =grade III) (OR=15.41, P=0.013). Compared with the baseline level, significant reductions in the MELD scores were observed on the 7th day after admission in the Recovery group (P=0.016). CONCLUSIONS: Dynamic changes in clinical parameters during admission are useful prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Acute-On-Chronic Liver Failure/*diagnosis/drug therapy/etiology
;
Adult
;
Aged
;
Antibodies, Monoclonal, Murine-Derived/therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Antiviral Agents/therapeutic use
;
Cyclophosphamide/therapeutic use
;
DNA, Viral/analysis
;
Doxorubicin/therapeutic use
;
Female
;
Hepatitis B virus/genetics
;
Hepatitis B, Chronic/complications/*diagnosis/drug therapy
;
Hospitalization
;
Humans
;
Liver Transplantation
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prednisone/therapeutic use
;
Prognosis
;
Retrospective Studies
;
Severity of Illness Index
;
Vincristine/therapeutic use
;
Young Adult